Could a tiny pill fight cancer treatment exhaustion?
NCT ID NCT07224009
Summary
This study aims to see if a very small daily dose of naltrexone (LDN) can safely reduce severe tiredness in men with prostate cancer who are receiving hormone therapy. Researchers will enroll 60 men who are experiencing significant fatigue from their treatment. The main goal is to measure if LDN improves energy levels and quality of life compared to current standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.